Benign and Malignant Tumors of the Brain
Data from the National Cancer Institute (NCI) indicate that approximately 17,600 individuals within the United States were expected to be diagnosed with a first primary cancer of the central nervous system (CNS) in 1997, of whom approximately 15% would be aged 70 years or more.1 Most of these individuals would die from their disease, with overall 5-year survival rates estimated to be approximately 30%.1 In addition, up to 100,000 Americans are diagnosed each year with metastatic brain lesions, most of whom are elderly patients. Although improved technology and treatment modalities have led to increased detection of brain lesions and better control of systemic primary malignancies, little progress has been made with respect to survival and identification of risk factors in individuals diagnosed with these lesions. The conflict between these two is particularly important in the elderly, given that Americans over the age of 70 years now make up the fastest growing portion of the U.S. population.2 This chapter provides a review and discussion of options for the detection, treatment, and outcome of elderly patients diagnosed with tumors of the brain.
KeywordsElderly Patient Brain Tumor Malignant Glioma Primary Brain Tumor Whole Brain Irradiation
Unable to display preview. Download preview PDF.
- 5.Roush GC, Holford TR, Schymura MJ. Cancer Risk and Incidence Trends: the Connecticut Perspective. New York: Hemisphere, 1987.Google Scholar
- 32.Hall WA, Cho KH, Lee A, Gerbi BJ, Lee CK. Solitary brain metastases: surgery, stereotactic radiosurgery and/or radiation therapy? Presented at the annual meeting of the Congress of Neurological Surgeons, Montreal 1997.Google Scholar